Literature DB >> 8384012

Virological and serological aspects of immune resistance to rotavirus gastroenteritis.

S Chiba1, S Nakata, S Ukae, N Adachi.   

Abstract

Some aspects of immune resistance to rotavirus gastroenteritis were assessed on the basis of clinical and laboratory findings during several outbreaks of gastroenteritis due to rotavirus of serotype 1 or 3 in a welfare nursery. Protection against rotavirus gastroenteritis was serotype specific and seemed to be related to levels of antibody to homotypic virus. The short duration of the protective effect may explain recurrent attacks of gastroenteritis due to the same serotype. Heterotypic antibody responses suggested that immunity to heterotypic virus can be induced by natural rotavirus infection or a rotavirus vaccine. Results of a field trial of a candidate vaccine, rhesus rotavirus strain MMU 18006, were used as a basis for evaluating strategies for vaccine development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384012     DOI: 10.1093/clinids/16.supplement_2.s117

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  Memory T-cell response to rotavirus detected with a gamma interferon enzyme-linked immunospot assay.

Authors:  Robin M Kaufhold; Jodie A Field; Michael J Caulfield; Su Wang; Heather Joseph; Melissa A Wooters; Tina Green; H Fred Clark; David Krah; Jeffrey G Smith
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  Antibody responses to human rotavirus (HRV) in gnotobiotic pigs following a new prime/boost vaccine strategy using oral attenuated HRV priming and intranasal VP2/6 rotavirus-like particle (VLP) boosting with ISCOM.

Authors:  A M González; T V Nguyen; M S P Azevedo; K Jeong; F Agarib; C Iosef; K Chang; K Lovgren-Bengtsson; B Morein; L J Saif
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

3.  Did Large-Scale Vaccination Drive Changes in the Circulating Rotavirus Population in Belgium?

Authors:  Virginia E Pitzer; Joke Bilcke; Elisabeth Heylen; Forrest W Crawford; Michael Callens; Frank De Smet; Marc Van Ranst; Mark Zeller; Jelle Matthijnssens
Journal:  Sci Rep       Date:  2015-12-21       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.